Shijiazhuang Yiling Pharmaceutical Co., Ltd.
Simbolis: 002603.SZ
SHZ
19.58
CNYRinkos kaina šiandien
12.0881
P/E santykis
0.2763
PEG koeficientas
32.71B
MRK kapitalizacija
- 0.03%
DIV pajamingumas
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603-SZ) Finansinės ataskaitos
Balansas
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
balance-sheet.row.cash-and-short-term-investments | 5918.12 | 2422.7 | 1050.5 | 1554 | |||||||||||||||
balance-sheet.row.short-term-investments | 960.06 | 518.4 | 55.3 | 217 | |||||||||||||||
balance-sheet.row.net-receivables | 11401.27 | 2699.6 | 2593.1 | 2102.4 | |||||||||||||||
balance-sheet.row.inventory | 9398.48 | 2021.8 | 1672.7 | 1580.3 | |||||||||||||||
balance-sheet.row.other-current-assets | 764.15 | 110.1 | 285.8 | 222.7 | |||||||||||||||
balance-sheet.row.total-current-assets | 27482.02 | 7254.2 | 5602.1 | 5459.4 | |||||||||||||||
balance-sheet.row.property-plant-equipment-net | 28847.51 | 6221.8 | 5745.5 | 4299.1 | |||||||||||||||
balance-sheet.row.goodwill | 458.41 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.intangible-assets | 1788.73 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.goodwill-and-intangible-assets | 2247.15 | 828 | 897.9 | 736.6 | |||||||||||||||
balance-sheet.row.long-term-investments | 6697.79 | 830.5 | -54.3 | -216 | |||||||||||||||
balance-sheet.row.tax-assets | 644.07 | 279.9 | 117 | 137.8 | |||||||||||||||
balance-sheet.row.other-non-current-assets | 3777.87 | 921.8 | 596.6 | 1075.3 | |||||||||||||||
balance-sheet.row.total-non-current-assets | 42214.38 | 9081.9 | 7302.7 | 6032.9 | |||||||||||||||
balance-sheet.row.other-assets | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.total-assets | 69696.4 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.account-payables | 9244.98 | 2060.8 | 1621.2 | 1188.4 | |||||||||||||||
balance-sheet.row.short-term-debt | 5000.64 | 656.3 | 513.9 | 270.2 | |||||||||||||||
balance-sheet.row.tax-payables | 514.42 | 474 | 123.2 | 133.9 | |||||||||||||||
balance-sheet.row.long-term-debt-total | 2224.33 | 215.1 | 513 | 10.5 | |||||||||||||||
Deferred Revenue Non Current | 1093.93 | 335 | 357.8 | 328.1 | |||||||||||||||
balance-sheet.row.deferred-tax-liabilities-non-current | 511.13 | - | - | - | |||||||||||||||
balance-sheet.row.other-current-liab | 969.93 | 1027.3 | 216.3 | 28.3 | |||||||||||||||
balance-sheet.row.total-non-current-liabilities | 3857.23 | 555.7 | 872.2 | 330.1 | |||||||||||||||
balance-sheet.row.other-liabilities | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.capital-lease-obligations | 53.78 | 15 | 12.5 | 10.5 | |||||||||||||||
balance-sheet.row.total-liab | 22620.85 | 5405.8 | 3832.7 | 2569 | |||||||||||||||
balance-sheet.row.preferred-stock | 0 | 0 | 0 | 0 | |||||||||||||||
balance-sheet.row.common-stock | 6682.82 | 1670.7 | 1670.7 | 1203.7 | |||||||||||||||
balance-sheet.row.retained-earnings | 26988.46 | 5989.2 | 4306.2 | 4324.4 | |||||||||||||||
balance-sheet.row.accumulated-other-comprehensive-income-loss | 8525.75 | 989 | 808.9 | 640.9 | |||||||||||||||
balance-sheet.row.other-total-stockholders-equity | 4566.63 | 2283.3 | 2283.3 | 2750.3 | |||||||||||||||
balance-sheet.row.total-stockholders-equity | 46763.66 | 10932.2 | 9069.1 | 8919.3 | |||||||||||||||
balance-sheet.row.total-liabilities-and-stockholders-equity | 69696.4 | 16336.1 | 12904.8 | 11492.3 | |||||||||||||||
balance-sheet.row.minority-interest | -40.48 | -1.9 | 3 | 4.1 | |||||||||||||||
balance-sheet.row.total-equity | 46723.18 | 10930.3 | 9072.2 | 8923.4 | |||||||||||||||
balance-sheet.row.total-liabilities-and-total-equity | 69696.4 | - | - | - | |||||||||||||||
Total Investments | 7657.84 | 1348.9 | 1 | 1 | |||||||||||||||
balance-sheet.row.total-debt | 7252.82 | 871.4 | 1026.9 | 270.2 | |||||||||||||||
balance-sheet.row.net-debt | 2294.75 | -1032.8 | 31.6 | -1066.8 |
Pinigų srautų ataskaita
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash-flows.row.net-income | 453.79 | 2356.8 | 1341.6 | 1214.9 | |||||||||||||||
cash-flows.row.depreciation-and-amortization | 18.64 | 451.5 | 362.9 | 268.2 | |||||||||||||||
cash-flows.row.deferred-income-tax | 0 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.stock-based-compensation | 0 | 158.7 | -20.1 | 67.7 | |||||||||||||||
cash-flows.row.change-in-working-capital | 0 | 547.8 | -1309.7 | 24.8 | |||||||||||||||
cash-flows.row.account-receivables | 0 | -831.7 | -1280.3 | -668.7 | |||||||||||||||
cash-flows.row.inventory | 0 | -348 | -104.7 | -364.9 | |||||||||||||||
cash-flows.row.account-payables | 0 | 1886.2 | 55.1 | 1126.1 | |||||||||||||||
cash-flows.row.other-working-capital | 0 | -158.7 | 20.1 | -67.7 | |||||||||||||||
cash-flows.row.other-non-cash-items | -279.24 | 131.6 | 133.9 | 78.3 | |||||||||||||||
cash-flows.row.net-cash-provided-by-operating-activities | -97.94 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.investments-in-property-plant-an-equipment | -266.96 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.acquisitions-net | -675.79 | 0.4 | 2.4 | 1145.1 | |||||||||||||||
cash-flows.row.purchases-of-investments | -2677.83 | -3461.9 | -451 | -2853.3 | |||||||||||||||
cash-flows.row.sales-maturities-of-investments | 4232.64 | 1680.7 | 616.6 | 2957.6 | |||||||||||||||
cash-flows.row.other-investing-activites | 0.36 | 0 | -1.2 | -1144.8 | |||||||||||||||
cash-flows.row.net-cash-used-for-investing-activites | 612.43 | -1994.8 | -506.8 | -1040.2 | |||||||||||||||
cash-flows.row.debt-repayment | -651.63 | -2200 | -1469.9 | -270 | |||||||||||||||
cash-flows.row.common-stock-issued | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.common-stock-repurchased | 0 | 0 | 0 | 0 | |||||||||||||||
cash-flows.row.dividends-paid | -1236.19 | -282.7 | -1220.1 | -244.1 | |||||||||||||||
cash-flows.row.other-financing-activites | 1548.01 | 1845.7 | 2387.9 | 490.8 | |||||||||||||||
cash-flows.row.net-cash-used-provided-by-financing-activities | -344.34 | -637 | -302.1 | -23.3 | |||||||||||||||
cash-flows.row.effect-of-forex-changes-on-cash | 0.6 | 1.2 | -0.5 | -2 | |||||||||||||||
cash-flows.row.net-change-in-cash | 168.43 | 857.2 | -280.7 | 520.8 | |||||||||||||||
cash-flows.row.cash-at-end-of-period | 4775.1 | 1810.7 | 953.5 | 1234.2 | |||||||||||||||
cash-flows.row.cash-at-beginning-of-period | 4606.67 | 953.5 | 1234.2 | 713.4 | |||||||||||||||
cash-flows.row.operating-cash-flow | -97.94 | 3487.7 | 528.7 | 1586.2 | |||||||||||||||
cash-flows.row.capital-expenditure | -266.96 | -214 | -673.6 | -1144.8 | |||||||||||||||
cash-flows.row.free-cash-flow | -364.9 | 3273.8 | -144.9 | 441.4 |
Pajamų ataskaitos eilutė
common:word.in-mln USD Growth | TTM | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | |||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
income-statement-row.row.total-revenue | 8836.76 | 12532.8 | 10116.8 | 8782.5 | |||||||||||||||
income-statement-row.row.cost-of-revenue | 4301.71 | 4540.6 | 3681 | 3118.4 | |||||||||||||||
income-statement-row.row.gross-profit | 4535.05 | 7992.3 | 6435.8 | 5664.1 | |||||||||||||||
income-statement-row.row.gross-profit-ratio | 0 | 0 | 0 | 0 | |||||||||||||||
income-statement-row.row.research-development | 860.36 | - | - | - | |||||||||||||||
income-statement-row.row.selling-general-administrative | 262.88 | - | - | - | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1358.25 | - | - | - | |||||||||||||||
income-statement-row.row.other-expenses | -42.42 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.operating-expenses | 3928.53 | 5025.8 | 4758.7 | 4179.2 | |||||||||||||||
income-statement-row.row.cost-and-expenses | 8230.24 | 9566.4 | 8439.7 | 7297.6 | |||||||||||||||
income-statement-row.row.interest-income | 22.9 | 12.9 | 20.4 | 7 | |||||||||||||||
income-statement-row.row.interest-expense | 42.41 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.selling-and-marketing-expenses | 1358.25 | - | - | - | |||||||||||||||
income-statement-row.row.total-other-income-expensenet | -24.14 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.ebitda-ratio-caps | 0 | - | - | - | |||||||||||||||
income-statement-row.row.other-operating-expenses | -42.42 | 576.9 | 366.6 | 323 | |||||||||||||||
income-statement-row.row.total-operating-expenses | -24.14 | -48.9 | -15.4 | -15.6 | |||||||||||||||
income-statement-row.row.interest-expense | 42.41 | 33.8 | 34 | 3.8 | |||||||||||||||
income-statement-row.row.depreciation-and-amortization | 124.37 | 546.1 | 448.6 | 329.5 | |||||||||||||||
income-statement-row.row.ebitda-caps | 747 | - | - | - | |||||||||||||||
income-statement-row.row.operating-income | 620.63 | 2829.6 | 1569.1 | 1438 | |||||||||||||||
income-statement-row.row.income-before-tax | 596.49 | 2780.6 | 1553.7 | 1422.5 | |||||||||||||||
income-statement-row.row.income-tax-expense | 151.7 | 423.8 | 212.1 | 207.5 | |||||||||||||||
income-statement-row.row.net-income | 453.79 | 2361.8 | 1343.9 | 1218.7 |
Dažnai užduodami klausimai
Kas yra Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) bendras turtas?
Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) bendras turtas yra 16336112689.000.
Kokios yra įmonės metinės pajamos?
Metinės pajamos yra 4197033558.000.
Kokia yra įmonės pelno marža?
Įmonės pelno marža yra 0.630.
Koks yra įmonės laisvųjų pinigų srautas?
Laisvųjų pinigų srautas yra 0.986.
Kokia yra įmonės grynojo pelno marža?
Grynojo pelno marža yra 0.206.
Kokios yra bendros įmonės pajamos?
Bendrosios pajamos yra 0.243.
Kas yra Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603.SZ) grynasis pelnas (grynosios pajamos)?
Grynasis pelnas (grynosios pajamos) yra 2361804714.000.
Kokia yra bendra įmonės skola?
Bendra skola yra 871449540.000.
Koks yra veiklos sąnaudų skaičius?
Veiklos sąnaudos yra 5025828583.000.
Koks yra įmonės grynųjų pinigų skaičius?
Įmonės grynieji pinigai yra 1189759394.000.